Clinical Trials Directory

Trials / Completed

CompletedNCT05665400

A Clinical Study for the Development of a Device (Lovelace) for Antepartum Fetal Monitoring

A Cross-sectional, Interventional, Exploratory Clinical Study for the Development of a Device (Lovelace) for Antepartum Fetal Monitoring

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
68 (actual)
Sponsor
Bloom Technologies · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Bloomlife Lovelace FT is a non-invasive, wireless, external measurement system used to measure accelerometer and electrophysiological signals on pregnant women with a singleton pregnancy, by acquiring biopotential signals from abdominal surface electrodes. In this study, Bloomlife Lovelace FT is used to collect the dataset needed for the development of a future product (Bloomlife Lovelace) for the monitoring of fetal heart rate, maternal heart rate and uterine activity.

Conditions

Interventions

TypeNameDescription
DEVICEBloomlife Lovelace FTBloomlife Lovelace FT is a non-invasive, wireless, external measurement system used to measure accelerometer and electrophysiological signals on pregnant women with a singleton pregnancy, by acquiring biopotential signals from abdominal surface electrodes.

Timeline

Start date
2022-07-13
Primary completion
2023-06-29
Completion
2023-11-30
First posted
2022-12-27
Last updated
2024-07-03

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05665400. Inclusion in this directory is not an endorsement.